KMT2C mutation is a diagnostic molecular marker for primary thyroid osteosarcoma: A case report and literature review

Xinpei Wang1,2, Qianqian Wang1, Peng Su3

  • 1Department of Pathology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Frontiers in Medicine
|November 25, 2022
PubMed